Tumor promoting effects of CD95 signaling in chemoresistant cells

BACKGROUND: CD95 is a death receptor controlling not only apoptotic pathways but also activating mechanisms promoting tumor growth. During the acquisition of chemoresistance to oxaliplatin there is a progressive loss of CD95 expression in colon cancer cells and a decreased ability of this receptor t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ametller, Elisabet, García-Recio, Susana, Costamagna, Domizziana, Mayordomo, Cristina, Fernández-Nogueira, Patricia, Carbó, Neus, Pastor-Arroyo, Eva María, Gascón, Pedro, Almendro, Vanessa
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906471/
https://www.ncbi.nlm.nih.gov/pubmed/20573240
http://dx.doi.org/10.1186/1476-4598-9-161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906471/
https://www.ncbi.nlm.nih.gov/pubmed/20573240
http://dx.doi.org/10.1186/1476-4598-9-161

Ejemplares similares